The US Food and Drug Administration (FDA) has approved a new indication for levofloxacin (Levaquin tablets/injection) to treat complicated skin and skin structure infections at a dose of 750 mg ...

Levofloxacin and placebo were given by parents or caregivers, and adherence was assessed with the use of questionnaires administered during the trial visits, treatment cards, and pill counts.

Prevention of drug-resistant tuberculosis is a global health priority. However, trials evaluating the effectiveness of treating Mycobacterium tuberculosis infection among contacts of persons with d ...

Of interest, the patient had no significant hypoglycemia associated with his first dose of levofloxacin and only experienced severe hypoglycemia when it was administered concomitantly with glipizide.

Sydney researchers have found that Levofloxacin substantially reduces risk of drug-resistant tuberculosis. This discovery offers new hope against a disease that infects more than 400,000 people ...

Levofloxacin was safe and reduced the risk for multidrug-resistant tuberculosis among children, adolescents and adults by 60% in two phase 3 trials, according to results presented at the Union ...

Levofloxacin, like all drugs in the fluoroquinolone class, has the potential for serious harm. I believe you have tendinopathy (inflammation in the tendons), which is among the more serious side ...

A clinical trial published in the New England Journal of Medicine showed that the oral antibiotic levofloxacin taken once-daily for six months substantially reduced the risk of developing drug ...

Find out how to take Levofloxacin(drug) and its dose. Describes the best time to take the drug and precautions if any that should be followed.

Levofloxacin, like all drugs in the fluoroquinolone class, has the potential for serious harm. I believe you have tendinopathy (inflammation in the tendons), which is among the more serious side ...

Levofloxacin revealed as first effective treatment for multi-drug resistant TB UCL researchers found that levofloxacin prevented MDR-TB by 60% Two landmark clinical trials involving researchers at ...